Evidence-based Text Messages to Target Diet and Physical Activity
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05641402 |
Recruitment Status :
Recruiting
First Posted : December 7, 2022
Last Update Posted : December 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Type 2 Diabetes | Other: Text messages | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 135 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Other |
Official Title: | Developing Evidence-based Text Messages to Target Diet and Physical Activity Behaviour for People With Type 2 Diabetes Mellitus |
Actual Study Start Date : | July 14, 2022 |
Estimated Primary Completion Date : | August 31, 2023 |
Estimated Study Completion Date : | October 29, 2023 |

Arm | Intervention/treatment |
---|---|
Experienced acceptability study
The final study in this research will involve people with type 2 diabetes receiving the text messages
|
Other: Text messages
Text messages based on behaviour change techniques |
- Experienced Acceptability of the text messages for people with type 2 diabetes [ Time Frame: 3.5 months ]Assessed through interviews following receiving the text messages
- Anticipated Acceptability [ Time Frame: 60 minutes ]Assessed through online survey
- Rating of fidelity to intended behaviour change technique [ Time Frame: 60 minutes ]
How well the text messages represent their intended behaviour change technique. For each behaviour change technique, participants will be presented with the title and description of the technique from the Behaviour change Technique (BCT) v1 taxonomy (Michie et al., 2013, doi: 10.1007/s12160-013-9486-6), and then sample messages. For each message participants will be asked "How well does this message reflect the [specific technique] as defined above?". Answers were given on a 10-point scale anchored with 1 (not very well) to 10 (very well).
This scale has been used in our previous work developing text messages (Bartlett et al., 2020, doi: 10.2196/15989)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
- For the expert workshop -
Inclusion criteria: researchers with expertise in behaviour change, physical activity, diet and/or diabetes
- For focus group
Inclusion criteria
- Participant is willing and able to give informed consent for participation in the study.
- Male or female, aged 18 years or above.
- A diagnosis of type 2 diabetes.
- Has access to a mobile-phone (shared access is allowed with permission of phone owner)
- Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages or messaging within smartphone applications).
Exclusion criteria
Moved out of England prior to taking part in the study
For the anticipated acceptability survey and experienced acceptability study
Inclusion criteria
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 years or above.
- A diagnosis of type 2 diabetes.
- Has access to a mobile-phone (shared access is allowed with permission of phone owner)
- Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages).
Exclusion criteria
- Within three months of a hospital admission for hyperglycaemia or hypoglycaemia.
- Pregnant or within three months post-partum by self-report
- Underweight (For anticipated acceptability this will be by self-report, for experienced acceptability BMI<18.5)
- Historical or current diagnosis of an eating disorder

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05641402
Contact: Kiera Bartlett, PhD | (+44)161 3065436 | kiera.bartlett@manchester.ac.uk | |
Contact: David P French, PhD | (0161) 275 2605 | david.french@manchester.ac.uk |
United Kingdom | |
University of Manchester | Recruiting |
Manchester, United Kingdom, M139PL | |
Contact: Kiera Bartlett, PhD (+44)161 3065436 kiera.bartlett@manchester.ac.uk |
Responsible Party: | Yvonne Kiera Bartlett, Lecturer, University of Manchester |
ClinicalTrials.gov Identifier: | NCT05641402 |
Other Study ID Numbers: |
NIHR202832 |
First Posted: | December 7, 2022 Key Record Dates |
Last Update Posted: | December 7, 2022 |
Last Verified: | November 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | Subject to participant consent. Plan to upload the deidentified survey data with codebook Will explore uploading deidentified transcripts if a relevant database is found |
Time Frame: | By December 2023 |
Access Criteria: | Dependent on the database chosen |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |